Lycia Therapeutics
LYCA31.4400.45% ( +0.140 )
Lycia Therapeutics (LYCA)
Lycia Therapeutics, Inc., a biotechnology company, engages in the discovery and development of therapeutics designed to degrade disease-causing extracellular pr...
- Open
- 31.500
- High
- 33.560
- Low
- 31.010
- Prev. Close
- 31.300
- Volume
- 329.59K
- Turnover
- 10.67M
- Avg Price
- 32.377
- Bid/Ask Ratio
- 33.33%
- Amplitude
- 8.15%
- 52wk High
- 36.493
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.97%
- 52wk Low
- 22.190
- Float Mkt Cap
- 1.06B
- Market CapUSD
- 1.81B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.521
- EPSDynamic
- -0.666
- EPSStatic
- --
- BVPS
- -2.29
- P/B
- --
- Circulating Supply
- 33.84M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 57.68M
- Min lot size
- 1
- Currency
- USD
News
- StockTitan ·
Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference | LYCA Stock News
- PUBT ·
Venrock Healthcare Capital Partners III, Affiliates Report Acquisition of $223,819.75 in Lycia Therapeutics Common Shares
- PUBT ·
Venrock Healthcare Capital Partners III Reports Acquisition of $644,711.28 in Lycia Therapeutics Common Shares
- Market Movers ·
Lycia Therapeutics surges 8%
